SG3 Management, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 116 filers reported holding RAPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.8%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$367,000
+18.0%
10,0000.0%0.01%
-22.2%
Q3 2021$311,000
-90.4%
10,000
-90.1%
0.01%
-92.2%
Q2 2021$3,227,000
+73.0%
101,500
+20.8%
0.12%
+150.0%
Q1 2021$1,865,00084,0000.05%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders